（文章来源：证券日报） 证券日报网讯 12月25日，国际医学在互动平台回答投资者提问时表示，自西安国际医学中心医院全面 开诊以来，公司整体业务规模实现了跨越式增长，营业收入从2019年的9.91亿元持续攀升至2024年的 48.2亿元，2024年度门诊量达257万人次/年，整体发展趋势稳健，品牌影响力与患者认可度不断提升。 同时，公司也在不断加强内部成本管控，优化管理流程，提升运营效能。随着公司经营业绩的逐步改 善，将进一步优化资本结构，降低负债水平。 ...

来源：新甘肃客户端 编辑：王学香责编：朱旺 校审：祁晴 面对养老与医疗服务的双重需求，金昌市创新构建了协议管理、居家签约、社区服务、内设机构、共融共建五种模式，系统推广"社区 +居家+机构"三位一体、"医疗+康复+照护+居家"四位一体等综合服务，实现了城乡社区"15分钟养老服务圈"的全覆盖。 在医疗服务支撑方面，金昌市持续加强老年健康服务能力建设。全市6家二级以上综合医院已全部设立老年病科，组建的110个家庭医生 团队，为老年人提供包括健康管理、上门巡诊、转诊协调在内的连续性服务，努力做到"慢病有管理、小病能处理、大病易转诊"，老年 人健康管理率超过80%。同时，中医药在医养结合中的作用得到充分发挥，基层医疗卫生机构普遍设立中医科和中药房，广泛推广适宜 技术与食疗保健方法。作为全国安宁疗护试点地区，金昌已初步建立起以市属医院为核心的服务网络，相关工作获得省级认可。 人才队伍建设与信息化应用为服务体系提供了坚实保障。"十四五"期间，金昌市通过实施专项培训计划，累计培训各类养老人才超过 3500人次，本地职业院校开设相关专业，年均培养专业人才200余人。在智慧养老方面，依托全民健康信息平台，建立了统一的医养结合 ...

Core Viewpoint - Aier Eye Hospital Group Co., Ltd. is acquiring partial equity stakes in 39 medical institutions to enhance its market competitiveness and improve its tiered medical service system [1]. Group 1: Stock Performance - As of December 25, 2025, Aier Eye's stock closed at 11.14 yuan, up 0.18% from the previous trading day, with a total market capitalization of 103.885 billion yuan [1]. - The stock opened at 11.15 yuan, reached a high of 11.17 yuan, and a low of 11.05 yuan, with a trading volume of 4.32 billion yuan and a turnover rate of 0.49% [1]. Group 2: Acquisition Details - The company plans to use its own funds amounting to 963.0228 million yuan to acquire partial equity in 39 medical institutions [1]. - This acquisition does not constitute a related party transaction or a major asset restructuring, and it does not require approval from the shareholders' meeting [1]. - Post-acquisition, the company will hold varying equity stakes in the targeted hospitals, which are primarily located in city and county-level areas, aiding in the implementation of tiered diagnosis and treatment policies and promoting the distribution of quality medical resources [1].

南财智讯12月25日电，何氏眼科公告，公司董事会近日收到董事、董事会秘书周晋峰先生提交的书面辞 职报告。周晋峰先生因个人原因申请辞去公司董事、董事会秘书职务，辞职后不再担任公司任何职务。 根据相关规定，其辞职报告自送达董事会之日起生效。截至公告披露日，周晋峰先生未持有公司股份， 亦不存在应当履行而未履行的承诺事项。为保证相关工作顺利开展，在聘任新的董事会秘书之前，暂由 公司总经理何星儒先生代为履行董事会秘书职责。公司董事会已提名何星儒先生为第三届董事会非独立 董事候选人，该议案尚需提交股东大会审议。 ...

从资金流向上来看，当日医疗服务板块主力资金净流出1.48亿元，游资资金净流出1.26亿元，散户资金净 流入2.75亿元。医疗服务板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 603127 昭衍新药 | | | 1.64Z | 17.48% | -2896.75万 | -3.09% | -1.35 Z | -14.39% | | 600721 百花医药 | | | 4582.71万 | 10.21% | -575.04万 | -1.28% | -4007.67万 | -8.93% | | 300347 泰格医药 | | | 4033.02万 | 5.57% | -2608.68万 | -3.60% | -1424.35万 | -1.97% | | 002173 创新医疗 | | | 3008.85万 | 3.17% | -2676.92万 | -2.82% | -331.9 ...

Group 1 - The core point of the article highlights the recent performance of Yueshen Health, with a stock price increase of 5.33% to 4.94 CNY per share, a trading volume of 140 million CNY, and a total market capitalization of 4.543 billion CNY [1] - Yueshen Health, established on June 8, 1993, and listed on August 23, 2007, operates in high-end ceramic tiles and ecological functional building materials, focusing on the "Yueshen Health" brand in healthcare and elderly services [1] - The revenue composition of Yueshen Health includes: 35.96% from marble tiles, 31.86% from antique tiles, 11.19% from health services, 8.71% from warehouse leasing, 6.71% from ceramic tiles, 5.09% from glass-ceramic tiles, and 0.48% from other tile products [1] Group 2 - The top circulating shareholder of Yueshen Health is the Guotai Fund, which holds 1.9629 million shares of the Guotai CSI All Index Building Materials ETF, accounting for 0.21% of the circulating shares [2] - The Guotai CSI All Index Building Materials ETF, established on June 9, 2021, has a current size of 1.102 billion CNY and has achieved a year-to-date return of 12.31% [2] - The fund manager, Huang Yue, has a tenure of 4 years and 325 days, with the fund's total asset size at 35.78 billion CNY, achieving a best return of 44.94% and a worst return of -60.42% during the tenure [3]

（来源：廊坊日报） 转自：廊坊日报 本报讯（记者 马颖劼）为弘扬尊师重教的优良传统，表达对退休教师的关怀与敬意，近日，廊坊一中 携手廊坊健康管理医院组织开展了离退休教师健康义诊活动，为曾耕耘讲台数十载的教育工作者们送上 了一份健康厚礼。 为精准回应离退休教师"常见病防治、慢性病管理、康复保健"等健康需求，学校工会与廊坊健康管理医 院提前精心筹备，组建了一支由内科、放射科、超声科资深专家组成的多学科爱心医疗团队走进家属院 社区，将优质服务送到了家门口。 活动现场，专家们俯身为离退休教师问诊、听诊、叩诊，翻看既往病历，对高血压、糖尿病、骨质疏松 等常见慢性病调养问题进行细致解答，还耐心宣传常见疾病的预防和保健知识，根据每位老师的身体状 况给予个性化的健康建议。 廊坊一中将持续关注退休教师的健康需求，不断丰富活动形式和内容，提升服务质量，为离退休教师的 健康保驾护航。 ...

Investment Rating - The report indicates a positive outlook for the healthcare sector, particularly the biopharmaceutical industry, which is expected to continue its recovery into 2026 [4][5]. Core Insights - The biopharmaceutical sector has shown significant recovery, with a 12% increase this year, narrowing the gap with the S&P 500 index, which has risen by 14% [2][3]. - Key drivers for this recovery include improved policy clarity regarding drug pricing and a resurgence in investor confidence in innovation across various therapeutic areas, particularly in obesity and cardiovascular diseases [3][4]. - The report highlights that major biopharmaceutical companies are experiencing upward revisions in sales expectations for the first time in years, indicating a positive shift in market sentiment [3][5]. Summary by Sections Biopharmaceutical Sector - The biopharmaceutical industry is expected to see sustained recovery, driven by clearer drug pricing policies and the initiation of new product cycles [4][5]. - Major companies like Amgen and Regeneron are anticipated to have upward performance potential, while BioGen is expected to improve due to stable earnings and catalysts [8]. - The report emphasizes the importance of mergers and acquisitions as a significant theme, with the industry likely entering a consolidation phase [8][12]. Medical Technology - The medical technology sector is projected to experience organic growth slowdown, but there are numerous product catalysts that could drive performance [25][26]. - Companies like Edwards and Abbott are highlighted as having significant growth potential, with expectations of increased merger activity [25][26]. Healthcare Services - The report discusses the managed care sector, indicating that it is currently in a typical underwriting cycle, with a potential recovery in Medicare Advantage plans expected in 2026 [32][33]. - The report suggests a cautious outlook for managed Medicaid plans and exchanges, with specific companies receiving varied ratings based on their performance and market conditions [33]. Investment Opportunities - The report identifies several stocks as potential investment opportunities for 2026, including UnitedHealth Group (UNH), Cytokinetics, and Abbott, among others [44].

您的浏览器不支持此视频格式 12月20日，江苏省免疫学会营养与免疫专委会第二届学术会议暨系列学术活动在连云港顺利召开。会议期间，连云港市第一人民医院成功举行 了X射线立体定向放射外科机器人"射波刀"的开机启用仪式，标志着该院肿瘤放射治疗正式迈入高精度、智能化新阶段。 北京中日友好医院质子医学中心副主任朱广迎、中国医师协会放疗专委会副会长尹勇、江苏省免疫学会秘书长朱一蓓、江苏省肿瘤医院副院长 何侠、江苏省免疫学会营养与免疫专委会主委孙治平等专家出席会议，并与连云港市第一人民医院院长施辉、副院长蒋晓东等共同为"射波 刀"开机揭幕。 射波刀是一种将直线加速器小型化并搭载于机器人控制臂的高精度放射治疗系统，具备全向聚焦、多角度入射、实时动态追踪肿瘤靶区等优 势，可实现更精准的治疗效果，并最大限度保护周围正常组织。 连云港市第一人民医院党委书记、院长施辉表示，此次学术会议的顺利召开与射波刀的正式启用，是医院积极响应"健康中国"战略、提升区域 肿瘤诊疗能力的重要举措。该院将以此次会议为契机，进一步推动肿瘤学科发展，加强临床研究与技术创新。 该院肿瘤放疗中心杨永留介绍，射波刀具有无创、精准、高效、安全等优势，适用于全身多部 ...

（来源：邯郸日报） 日前，邯郸市第四医院组织神内二科、中医科、消化内科、儿童康复中心、急诊科、B超室的多位业务骨干组成义诊团队，走进峰峰镇人民社 区开展巡回诊疗活动。 韩英杰 摄 转自：邯郸日报 ...